International Flavors & Fragrances (IFF) Stock Price & Analysis
IFF Stock Chart & Stats
- Day’s Range
- EUR 80.98 - EUR 80.98
- 52-Week Range
- EUR 53.38 - EUR 83.88
- Previous Close
- EUR 81.14
- Volume
- N/A
- Average Volume (3M)
- 25
- Market Cap
- EUR 21.25B
- Enterprise Value
- EUR 26.07B
- Total Cash (Recent Filing)
- EUR 569.00M
- Total Debt (Recent Filing)
- EUR 6.24B
- Price to Earnings (P/E)
- 85.3
- Beta
- 0.73
- Next Earnings
- Nov 03, 2026 (Est.)
- EPS Estimate
- 0.73
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- 1.75%
Bulls Say, Bears Say
Bulls Say
Improving Cash Generation
Material improvement in operating and free cash flow creates durable funding for debt reduction, R&D and capex, and the planned buyback program. Strong FCF reduces refinancing risk and gives management flexibility to execute strategic priorities through cycles.
Portfolio Focus On Higher‑Margin Cores
Divesting Food Ingredients and concentrating on Taste, Scent and Health & Biosciences aligns the business toward higher-growth, higher-margin categories. Proceeds fund deleveraging and buybacks while sharpened portfolio and retained minority stake preserve strategic collaboration and upside.
Meaningful Deleveraging
Substantial debt reduction materially improves balance-sheet resilience, lowers covenant and liquidity risk, and expands capacity to pursue buybacks and reinvestment. Better leverage increases financial optionality and reduces sensitivity to interest-rate or macro shocks.
Bears Say
Divestiture Separation Costs & Working‑Capital Risk
The Food Ingredients carve‑out leaves ~ $100M of stranded costs and a sizable working‑capital unwind that can impair near‑term cash conversion. Timing and magnitude of these separation impacts could delay deleveraging, reduce available buyback capacity, and create persistent margin noise.
Low Returns And Thin Margins
Very low profitability and ROE indicate weak capital efficiency; returns currently insufficient to fully fund growth and shareholder returns. This increases reliance on divestitures and balance-sheet fixes and makes margins more vulnerable to input-cost or volume setbacks.
Top‑Line Weakness
Persistent revenue decline undermines scale benefits: it compresses pricing leverage, limits ability to expand margins, and constrains organic reinvestment. Even with portfolio reshaping, restoring consistent mid‑term revenue growth is a structural execution hurdle for durable improvement.
International Flavors & Fragrances News
IFF FAQ
What was International Flavors & Fragrances’s price range in the past 12 months?
What is International Flavors & Fragrances’s market cap?
When is International Flavors & Fragrances’s upcoming earnings report date?
How were International Flavors & Fragrances’s earnings last quarter?
Is International Flavors & Fragrances overvalued?
Does International Flavors & Fragrances pay dividends?
What is International Flavors & Fragrances’s EPS estimate?
How many shares outstanding does International Flavors & Fragrances have?
What happened to International Flavors & Fragrances’s price movement after its last earnings report?
Which hedge fund is a major shareholder of International Flavors & Fragrances?
What is the TipRanks Smart Score and how is it calculated?
International Flavors & Fragrances Stock Smart Score
Company Description
International Flavors & Fragrances
International Flavors & Fragrances Inc. (IFF), through its various subsidiaries, operates as a global developer and purveyor of active cosmetic and natural health ingredients. These vital components are incorporated into a wide array of consumer goods distributed across significant markets such as Europe, Africa, the Middle East, Greater Asia, North America, and Latin America. The company's activities are organized into four principal divisions: 1. Nourish: This segment focuses on natural and plant-derived specialty food ingredients, offering items like flavor compounds, savory solutions, and inclusions. It also provides natural food protection solutions, including antioxidants and anti-microbials, for use in beverages, confectionery, and dairy items. 2. Scent: The Scent division creates fragrance compounds, encompassing luxurious fine fragrances (perfumes and colognes) and everyday consumer fragrances. It further supplies essential fragrance ingredients, both synthetic and natural, which are blended to formulate new scents. Additionally, this segment delivers cosmetic active ingredients, such as functional compounds, botanicals, and advanced delivery systems, designed to enhance customers' cosmetic and personal care product lines. 3. Health & Biosciences: This segment is dedicated to the research, development, and production of enzymes, food cultures, probiotics, and other specialized biological ingredients. 4. Pharma Solutions: This division is responsible for manufacturing and distributing cellulosic and seaweed-derived pharmaceutical excipients. IFF's diverse customer base primarily consists of manufacturers in sectors including perfumery, cosmetics, hair and personal care, soaps and detergents, cleaning products, dairy, meat and processed foods, beverages, snacks and savory items, sweet and baked goods, dietary supplements, infant and elderly nutrition, functional foods, and producers of pharmaceutical excipients and oral care products. Established in 1833, International Flavors & Fragrances Inc. is headquartered in New York, New York.
- Sector
- Basicmaterials
- Industry
- Chemicals - Specialty
- CEO
- Jon Erik Fyrwald
- Employees
- 21,500
- Website
- www.iff.com
- Address
- 521 West 57th Street, New York City, NY, 10019-2960, US
International Flavors & Fragrances (IFF) Earnings & Revenues
IFF Company Deck
IFF Earnings Call
Earnings Call SentimentPositive
The call conveyed strong operational momentum and strategic progress: broad-based volume-driven growth across the remaining core segments (Taste, Scent, Health & Biosciences), meaningful free cash flow improvement, a major value-creating divestiture (Food Ingredients) at ~10x EV/EBITDA, and a clear plan to deleverage and return capital to shareholders. Offsetting these positives are near-term headwinds tied to the divestiture (roughly $100M of stranded costs and a working capital unwind that could be a couple hundred million), modest input-cost inflation with some pricing lag, and geopolitical/commodity-related volatility that widens guidance ranges. Management provided remediation plans and credible targets for cost elimination and deleveraging, and reiterated R&D and reinvestment commitments for the Remainco portfolio, supporting confidence in medium-term margin and cash-flow improvement.
View all DE:IFF earnings summariesIFF Net sales Breakdown
- 22.78% Taste
- 30.10% Food Ingredients
- 22.76% Scent
- 3.39% Pharma Solutions
- 20.96% Health & Biosciences
IFF Stock 12 Month Forecast
Average Price Target
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 11 | 6 | 5 |
| Technical Analysis | 3 | 6 | 1 |
| Moving Averages | 8 | 0 | 4 |
